Drug firm Zydus Cadila gets USFDA nod for cholesterol, antipsychotic drugs
Updated : August 30, 2018 03:00 PM IST
The company has received USFDA's final clearance to market Gemfibrozil tablets in strength of 600 mg and the other product in strengths of 10 mg, 15 mg, 20 mg, and 30 mg, Zydus Cadila said in a statement.
Gemfibrozil tablets are used together with diet to treat very high cholesterol and triglyceride levels in people with pancreatitis, Zydus Cadila said.
Aripiprazole is an atypical antipsychotic. The drug is used to treat certain mental/mood disorders, such as bipolar disorder, schizophrenia, Tourette's disorder, and irritability associated with autistic disorder.